DK1086097T3 - Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler - Google Patents
Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midlerInfo
- Publication number
- DK1086097T3 DK1086097T3 DK99921043T DK99921043T DK1086097T3 DK 1086097 T3 DK1086097 T3 DK 1086097T3 DK 99921043 T DK99921043 T DK 99921043T DK 99921043 T DK99921043 T DK 99921043T DK 1086097 T3 DK1086097 T3 DK 1086097T3
- Authority
- DK
- Denmark
- Prior art keywords
- inflammatory
- analgesic agents
- sulfonylbenzene
- compounds
- sulfonylbenzene compounds
- Prior art date
Links
- VTILWYBQQRECER-UHFFFAOYSA-N 5-sulfonylcyclohexa-1,3-diene Chemical class O=S(=O)=C1CC=CC=C1 VTILWYBQQRECER-UHFFFAOYSA-N 0.000 title 1
- 239000000730 antalgic agent Substances 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB9800912 | 1998-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1086097T3 true DK1086097T3 (da) | 2004-08-09 |
Family
ID=11004725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99921043T DK1086097T3 (da) | 1998-06-11 | 1999-05-31 | Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1086097B1 (da) |
| JP (1) | JP2002517496A (da) |
| AP (1) | AP9901578A0 (da) |
| AT (1) | ATE267196T1 (da) |
| AU (1) | AU3841499A (da) |
| DE (1) | DE69917451T2 (da) |
| DK (1) | DK1086097T3 (da) |
| ES (1) | ES2220060T3 (da) |
| GT (1) | GT199900081A (da) |
| MA (1) | MA26642A1 (da) |
| PA (1) | PA8475401A1 (da) |
| PT (1) | PT1086097E (da) |
| TN (1) | TNSN99111A1 (da) |
| WO (1) | WO1999064415A1 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515014B2 (en) | 1995-06-02 | 2003-02-04 | G. D. Searle & Co. | Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| WO2000066562A1 (en) * | 1999-05-03 | 2000-11-09 | Dr. Reddy's Research Foundation | Pyrazoles having antiinflammatory activity |
| EA008242B1 (ru) | 1999-12-08 | 2007-04-27 | Фармация Корпорейшн | Композиции на основе ингибитора циклооксигеназы-2 с быстро наступающим терапевтическим действием и способы лечения заболеваний |
| US6649629B2 (en) | 1999-12-23 | 2003-11-18 | Nitromed, Inc. | Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| AU2001253749A1 (en) * | 2000-04-25 | 2001-11-07 | Pharmacia Corporation | 2-fluorobenzenesulfonyl compounds for the treatment of inflammation |
| ES2166710B1 (es) * | 2000-04-25 | 2004-10-16 | J. URIACH & CIA, S.A. | Nuevos compuestos heterociclicos con actividad antiinflamatoria. |
| AU2001258677A1 (en) * | 2000-05-22 | 2001-12-03 | Dr. Reddy's Research Foundation | Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them |
| RU2288225C2 (ru) * | 2000-05-22 | 2006-11-27 | Др. Редди`З Лабораториз Лимитед | Новые соединения, обладающие противовоспалительной активностью, и содержащие их фармацевтические композиции |
| GB0016787D0 (en) | 2000-07-07 | 2000-08-30 | Pfizer Ltd | Compounds useful in therapy |
| US6673818B2 (en) | 2001-04-20 | 2004-01-06 | Pharmacia Corporation | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
| ES2184633B1 (es) | 2001-08-07 | 2004-08-01 | J. URIACH & CIA, S.A. | Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida. |
| US7211598B2 (en) | 2002-06-28 | 2007-05-01 | Nitromed, Inc. | Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| ES2215474B1 (es) | 2002-12-24 | 2005-12-16 | J. URIACH & CIA S.A. | Nuevos derivados de fosforamida. |
| ES2275218T3 (es) | 2003-05-07 | 2007-06-01 | Osteologix A/S | Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos. |
| GB0315111D0 (en) | 2003-06-27 | 2003-07-30 | Cancer Rec Tech Ltd | Substituted 5-membered ring compounds and their use |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| GB0514738D0 (en) * | 2005-07-19 | 2005-08-24 | Astrazeneca Ab | Therapeutic agents |
| CN101830909A (zh) * | 2010-04-26 | 2010-09-15 | 西安近代化学研究所 | 4氢-环戊[2,1-b;3,4-b′]双噻吩酮的制备方法 |
| CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
| CN116425719B (zh) * | 2023-04-13 | 2025-04-08 | 武汉理工大学 | 一种塞来昔布菲啶化衍生物及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2217284A1 (de) * | 1971-04-19 | 1972-11-02 | Ciba-Geigy Ag, Basel (Schweiz) | Neue Pyrazolinverbindungen als optische Aufheller |
| US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| DE2310446A1 (de) * | 1973-03-02 | 1974-09-05 | Bayer Ag | Aufhellungsmittel |
| US3839325A (en) * | 1973-03-23 | 1974-10-01 | Gaf Corp | Synthesis of 4-sulfonamidophenyl hydrazines |
| US4259504A (en) * | 1979-08-27 | 1981-03-31 | American Cyanamid Company | Substituted 1H-1,2,4-triazoles |
| PH27357A (en) * | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| WO1996003392A1 (en) * | 1994-07-27 | 1996-02-08 | G.D. Searle & Co. | Substituted thiazoles for the treatment of inflammation |
| US5585504A (en) * | 1994-09-16 | 1996-12-17 | Merck & Co., Inc. | Process of making cox-2 inhibitors having a lactone bridge |
| EP0799218B1 (en) * | 1994-12-21 | 2003-02-19 | Merck Frosst Canada & Co. | Diaryl-2-(5h)-furanones as cox-2 inhibitors |
| DE19518082A1 (de) * | 1995-05-17 | 1996-11-21 | Merck Patent Gmbh | 4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one |
| US5756529A (en) * | 1995-09-29 | 1998-05-26 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies |
| FR2753449B1 (fr) * | 1996-09-13 | 1998-12-04 | Union Pharma Scient Appl | Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique |
| IT1287174B1 (it) * | 1996-11-15 | 1998-08-04 | Angelini Ricerche Spa | Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono |
-
1998
- 1998-06-11 TN TNTNSN99111A patent/TNSN99111A1/fr unknown
-
1999
- 1999-05-31 WO PCT/IB1999/000970 patent/WO1999064415A1/en not_active Ceased
- 1999-05-31 DK DK99921043T patent/DK1086097T3/da active
- 1999-05-31 AU AU38414/99A patent/AU3841499A/en not_active Abandoned
- 1999-05-31 ES ES99921043T patent/ES2220060T3/es not_active Expired - Lifetime
- 1999-05-31 AT AT99921043T patent/ATE267196T1/de not_active IP Right Cessation
- 1999-05-31 PT PT99921043T patent/PT1086097E/pt unknown
- 1999-05-31 JP JP2000553424A patent/JP2002517496A/ja not_active Withdrawn
- 1999-05-31 EP EP99921043A patent/EP1086097B1/en not_active Expired - Lifetime
- 1999-05-31 DE DE69917451T patent/DE69917451T2/de not_active Expired - Fee Related
- 1999-06-09 GT GT199900081A patent/GT199900081A/es unknown
- 1999-06-09 PA PA19998475401A patent/PA8475401A1/es unknown
- 1999-06-09 MA MA25614A patent/MA26642A1/fr unknown
- 1999-06-10 AP APAP/P/1999/001578A patent/AP9901578A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002517496A (ja) | 2002-06-18 |
| ATE267196T1 (de) | 2004-06-15 |
| WO1999064415A1 (en) | 1999-12-16 |
| PA8475401A1 (es) | 2000-09-29 |
| MA26642A1 (fr) | 2004-12-20 |
| GT199900081A (es) | 2000-11-30 |
| AP9901578A0 (en) | 1999-06-30 |
| DE69917451D1 (de) | 2004-06-24 |
| ES2220060T3 (es) | 2004-12-01 |
| AU3841499A (en) | 1999-12-30 |
| DE69917451T2 (de) | 2005-05-12 |
| EP1086097A1 (en) | 2001-03-28 |
| PT1086097E (pt) | 2004-08-31 |
| EP1086097B1 (en) | 2004-05-19 |
| TNSN99111A1 (fr) | 2005-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20014412D0 (no) | Forbindelser nyttige som anti-inflammatoriske midler | |
| NO20012562L (no) | Ikke-steroide antiinflammatoriske forbindelser | |
| NO20041339D0 (no) | Spiro-hydantoin-forbindelser anvendelige som anti-inflammatoriske midler | |
| NO20003930L (no) | Sammensetninger som inneholder organiske forbindelser | |
| ATE229954T1 (de) | Betacarbolinverbindungen | |
| ID28266A (id) | Senyawa-senyawa amidin | |
| NO20011745L (no) | Forbindelser | |
| FI4209U1 (fi) | Uusia yhdisteitä | |
| NO992692D0 (no) | Nefadozon doseringsform | |
| DK0975623T3 (da) | Indazolamidforbindelser som sertoninerge midler | |
| AU3841499A (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents | |
| DE69908845D1 (de) | Fotoresistzusammensetzung | |
| ID27004A (id) | Senyawa-senyawa kalsilitik | |
| NO20012965D0 (no) | Sulfonyloksazolaminer som terapeutisk aktive forbindelser | |
| NO20006662L (no) | Fluorfenylresin-forbindelser | |
| DK1075471T3 (da) | Idolylderivater som serotonerge midler | |
| ATE269383T1 (de) | Benzin-sauerstoffverbindungen-gemisch | |
| NO20011402L (no) | Tricykliske <delta>3-piperidiner som farmasöytiske midler | |
| NO20002321D0 (no) | Bifenylderivater som farmasøytiske midler | |
| ZA993897B (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
| SE9802539D0 (sv) | New pharmaceutically active compounds | |
| SE9800834D0 (sv) | New Compounds | |
| SE9800512D0 (sv) | New compounds | |
| SE9800511D0 (sv) | New compounds | |
| SE9800510D0 (sv) | New Compounds |